News | May 08, 2023
Galmed Pharmaceuticals forms partnership with OnKai
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The collaboration between CORONA and Ferring will cater to patients across India
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Bridging the gap between histopathology and molecular pathology
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
Subscribe To Our Newsletter & Stay Updated
